Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
Go back to Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 32.85 +0.77 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.08 | 52 Week High | $4.38 | |||
| Open | $32.08 | 52 Week Low | $1.88 | |||
| Day High | $33.57 | P/E | N/A | |||
| Day Low | $31.90 | EPS | $-1.12 | |||
| Volume | 241,692 | |||||
